Sarah M. Cheal
Memorial Sloan Kettering Cancer Center(US)Cornell University(US)Molecular Innovations (United States)(US)
Publications by Year
Research Areas
Radiopharmaceutical Chemistry and Applications, Monoclonal and Polyclonal Antibodies Research, Medical Imaging Techniques and Applications, Prostate Cancer Treatment and Research, Neuroblastoma Research and Treatments
Most-Cited Works
- → A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer(2015)203 cited
- → Clinically-translated silica nanoparticles as dual-modality cancer-targeted probes for image-guided surgery and interventions(2012)176 cited
- → 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer(2014)154 cited
- → First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake(2016)142 cited
- → Humanized Affinity-matured Monoclonal Antibody 8H9 Has Potent Antitumor Activity and Binds to FG Loop of Tumor Antigen B7-H3(2015)112 cited
- → 18F-Labeled-Bioorthogonal Liposomes for In Vivo Targeting(2013)84 cited